BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3262820)

  • 1. Ciclosporin treatment in experimental autoimmune myasthenia gravis.
    Gunn HC; Hiestand PC; Hanglow AC
    Monogr Allergy; 1988; 25():96-107. PubMed ID: 3262820
    [No Abstract]   [Full Text] [Related]  

  • 2. Interim report of clinical studies presented at the International Symposium on Ciclosporin in Auto-Immune Diseases, Basel, March 18-20, 1985.
    Schmitz-Schumann M
    Prog Allergy; 1986; 38():436-46. PubMed ID: 3755240
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental autoimmunity.
    Nussenblatt RB; Gunn HC; Ryffel B; Borel JF
    Prog Allergy; 1986; 38():159-80. PubMed ID: 3487790
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis.
    Goulon M; Elkharrat D; Lokiec F; Gajdos P
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):211-7. PubMed ID: 3260050
    [No Abstract]   [Full Text] [Related]  

  • 6. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
    Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
    Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopharmacological treatment in myasthenia gravis.
    Nyberg-Hansen R; Gjerstad L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):201-10. PubMed ID: 3289206
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes.
    Mathews CE
    Pediatr Diabetes; 2005 Sep; 6(3):165-77. PubMed ID: 16109074
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenic autoantibodies.
    Bach JF
    Contrib Microbiol Immunol; 1989; 11():263-88. PubMed ID: 2684511
    [No Abstract]   [Full Text] [Related]  

  • 10. Ciclosporin in the treatment of myasthenia gravis.
    Tindall RS; Phillips JT; Rollins JA; Greenlee RG; Wells L; Belendiuk G
    Monogr Allergy; 1988; 25():135-47. PubMed ID: 3173362
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies in cyclosporine A-induced autoimmune disease.
    Wodzig KW; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
    Transplant Proc; 1990 Dec; 22(6):2586-7. PubMed ID: 2264163
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune diseases in domestic animals.
    Halliwell RE
    J Am Vet Med Assoc; 1982 Nov; 181(10):1088-96. PubMed ID: 6129234
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromosome aberrations in F1 (NZBxNZW) mice--an experimental model of systemic lupus erythematosus].
    Skazkina OIa; Lil'p IG; Pleskovskaia GN; Tugolukova SS; Korogodina IuV
    Tsitol Genet; 1984; 18(6):458-9. PubMed ID: 6441320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine for myasthenia gravis.
    Elkharrat D; Goulon M; Gajdos P
    N Engl J Med; 1987 Sep; 317(12):770. PubMed ID: 3306381
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and cure of type 1 diabetes in the BB rat by islet allotransplantation and glimepiride treatment.
    Pan J; Chan EK; Yu E; Chen J; Schranz V; Charles MA
    Transplant Proc; 1995 Dec; 27(6):3194. PubMed ID: 8539908
    [No Abstract]   [Full Text] [Related]  

  • 16. Blepharospasm and autoimmune diseases.
    Jankovic J; Patten BM
    Mov Disord; 1987; 2(3):159-63. PubMed ID: 3509774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy].
    Schumacher K; Gross R
    Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of corticosteroids on the motor end-plate fine structure in experimental autoimmune myasthenia gravis rats and normal rats].
    Satoh A; Tsujihata M; Takashima H; Hazama R; Nagataki S
    Rinsho Shinkeigaku; 1985 Aug; 25(8):990-1000. PubMed ID: 3877587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental approach to the pathogenesis of systemic lupus erythematosus].
    Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA
    J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.